Authorities in Oregon last week issued the first business license under the state’s psilocybin therapy program.
Licensee, Satori Farms PDX LLC, has been granted permission to manufacture psilocybin products from theOregon Psilocybin Services – a branch of theOregon Health Authority – last Wednesday.
Oregon’s medical psilocybin program was officially launched last January, after voters approved the system in the 2020 election.
Psilocybin, a psychedelic substance present in certain mushrooms, called “magic mushrooms”, has shown promise in the treatment of severe depression, post-traumatic stress disorder, anxiety at the end of life in patients in phase terminal and certain mental disorders. Although the substance remains banned at the federal level, the Food and Drug Administration (FDA) granted psilocybin mushrooms “breakthrough therapy” status for major depressive disorder in 2018, which has resulted in clinical trials.
I’Oregon Psilocybin Services warned that the program could be slow to roll out because regulators must first review applications for four different types of licenses: production, analytics, service centers and enablers.
The start of the month also marked the culmination of Portland-based InnerTrek’s first-ever psilocybin training program, which teaches students how to accompany patients on psilocybin during their psychedelic experiences.
Earlier this month, Oregon psychedelic medicine advocates launched the Psychedelic Medicine PACa new political action committee intended to support electoral candidates in favor of the use of psychedelics for therapeutic purposes.
